Templeton Investment Counsel, LLC - Net Worth and Insider Trading

Templeton Investment Counsel, LLC Net Worth

The estimated net worth of Templeton Investment Counsel, LLC is at least $93 Million dollars as of 2024-06-17. Templeton Investment Counsel, LLC is the 2102 Investment manager of Shanghai Haohai Biological Technology Co Ltd and owns about 2,962,820 shares of Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) stock worth over $93 Million. Details can be seen in Templeton Investment Counsel, LLC's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Templeton Investment Counsel, LLC has not made any transactions after 2022-10-12 and currently still holds the listed stock(s).

Transaction Summary of Templeton Investment Counsel, LLC

Templeton Investment Counsel, LLC Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Templeton Investment Counsel, LLC owns 1 companies in total, including Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) .

Click here to see the complete history of Templeton Investment Counsel, LLC’s form 4 insider trades.

Insider Ownership Summary of Templeton Investment Counsel, LLC

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:06826	Shanghai Haohai Biological Technology Co Ltd	2022-10-12	2102 Investment manager

Templeton Investment Counsel, LLC Latest Holdings Summary

Templeton Investment Counsel, LLC currently owns a total of 1 stock. Templeton Investment Counsel, LLC owns 2,962,820 shares of Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) as of October 12, 2022, with a value of $93 Million.

Latest Holdings of Templeton Investment Counsel, LLC

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:06826	Shanghai Haohai Biological Technology Co Ltd	2022-10-12	2,962,820	31.40	93,032,548

Holding Weightings of Templeton Investment Counsel, LLC

Templeton Investment Counsel, LLC Form 4 Trading Tracker

According to the SEC Form 4 filings, Templeton Investment Counsel, LLC has made a total of 4 transactions in Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Shanghai Haohai Biological Technology Co Ltd is the sale of 215,320 shares on October 12, 2022, which brought Templeton Investment Counsel, LLC around $3 Million.

Insider Trading History of Templeton Investment Counsel, LLC

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Templeton Investment Counsel, LLC Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Templeton Investment Counsel, LLC Ownership Network

Ownership Network List of Templeton Investment Counsel, LLC

No Data

Ownership Network Relation of Templeton Investment Counsel, LLC

Templeton Investment Counsel, LLC Owned Company Details

What does Shanghai Haohai Biological Technology Co Ltd do?

Who are the key executives at Shanghai Haohai Biological Technology Co Ltd?

Templeton Investment Counsel, LLC is the 2102 Investment manager of Shanghai Haohai Biological Technology Co Ltd. Other key executives at Shanghai Haohai Biological Technology Co Ltd include 2201 Interest of corporation controlled by you Morgan Stanley , 2102 Investment manager Dalton Investments Llc , and 2201 Interest of corporation controlled by you The Bank Of New York Mellon Corporation .

Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) Insider Trades Summary

Over the past 18 months, Templeton Investment Counsel, LLC made no insider transaction in Shanghai Haohai Biological Technology Co Ltd (HKSE:06826). Other recent insider transactions involving Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) include a net sale of 143,449 shares made by Morgan Stanley ,

In summary, during the past 3 months, insiders sold 0 shares of Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 200,829 shares of Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) were sold and 0 shares were bought by its insiders, resulting in a net sale of 200,829 shares.

Shanghai Haohai Biological Technology Co Ltd (HKSE:06826)'s detailed insider trading history can be found in Insider Trading Tracker table.

Shanghai Haohai Biological Technology Co Ltd Insider Transactions

No Available Data

Templeton Investment Counsel, LLC Mailing Address

Above is the net worth, insider trading, and ownership report for Templeton Investment Counsel, LLC. Currently GuruFocus does not have mailing address information for Templeton Investment Counsel, LLC.

Discussions on Templeton Investment Counsel, LLC

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.